Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over

Int Psychogeriatr. 2000 Sep;12(3):379-87. doi: 10.1017/s1041610200006487.

Abstract

We examined 510 subjects representing 83.2% of all citizens of a Finnish city aged 85 years or over. Mini-Mental State Examination (MMSE) scores, diagnosis of dementia by DSM-III-R criteria, and Apo-E genotype were determined. The prevalence of dementia was 38.6%. The odds ratio (OR) of the Apo-E epsilon4 carriers (with the reference population of people with the genotype epsilon3/epsilon3) for dementia was 2.36 (95% CI 1.58 - 3.53). There was a significant sex difference: The OR in women was 3.23 (95% CI 2.02 - 5.17) whereas among men it was insignificant. The mean MMSE score (+/- SD) among the Apo-E epsilon4 carriers (15.0 +/- 10.0) and noncarriers (18.7 8.6) (p < .001) differed among the whole population, but not within the demented or nondemented subjects analyzed separately. This study does not support the hypothesis that the Apo-E epsilon4 allele impairs cognitive functions of nondemented elderly, at least in those surviving to very old age.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Alleles
  • Apolipoproteins E / metabolism*
  • Catchment Area, Health
  • Cognition Disorders / diagnosis*
  • Dementia / diagnosis*
  • Dementia / epidemiology
  • Dementia / metabolism*
  • Female
  • Finland / epidemiology
  • Genotype
  • Humans
  • Male
  • Neuropsychological Tests
  • Population Surveillance*
  • Severity of Illness Index
  • Sex Distribution

Substances

  • Apolipoproteins E